The Japanese Journal of Antibiotics
Online ISSN : 2186-5477
Print ISSN : 0368-2781
ISSN-L : 0368-2781
TOXICOLOGICAL STUDIES ON A NEW MACROLIDE ANTIBIOTIC, MIDECAMYCIN ACETATE (MIOCAMYCIN)
PART III-2. CHRONIC TOXICITY IN BEAGLE DOGS: 13-WEEK-TREATMENT IN MALE DOGS
MASAYUKI YOKOTAUETO TAKEDAMASUZO ODAKIHITOSHI SASAKITETSUTARO NIIZATOHARUO KAWAOTOKAZUNOBU KUMAGAIHEIJIRO SUZUKIMIDORI SUZUKINORIKO SUGIYAMATAKEMI KOEDA
著者情報
ジャーナル フリー

1984 年 37 巻 7 号 p. 1377-1382

詳細
抄録

Miocamycin (MOM) is a derivative of midecamycin, a macrolide antibiotic isolated from a culture broth of Streptomyces mycarofaciens1, 2).
The objective of this study was to determine the chronic toxicity of MOM in male Beagle dogs after once daily repeated p. o. administration of MOM, non-crystalline solid, for 13 weeks at daily dosage of 200 and 400mg/kg.
It is concluded that no toxic effects of MOM, non-crystalline solid, were shown in the present studies.
Therefore, the maximum non-toxic dose is presumed to be 400mg/kg or more in male Beagle dogs administered p. o. once daily for 13 weeks.

著者関連情報
© Japan Antibiotics Research Association
前の記事 次の記事
feedback
Top